This pathology presents as an array of molecularly distinct subtypes, categorized by hormonal receptor and HER2 statuses—namely hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+), and triple-negative breast cancer (TNBC). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.